The Therapeutic Strategies Targeting Mitochondrial Metabolism in Cardiovascular DiseaseXiaoyang Huang, Xiaoyong Tong, Zhenhua Zeng et al.|Pharmaceutics|2022Cited by 22
Substitution of SERCA2 Cys674 aggravates cardiac fibrosis by promoting the transformation of cardiac fibroblasts to cardiac myofibroblastsXiaoyang Huang, Xiaoyong Tong, Xiaojuan Lin et al.|Biochemical Pharmacology|2022Cited by 12
SERCA2 dysfunction stimulates inflammation and causes pulmonary vascular remodeling by downregulating PPARγ/PGC1α/Nrf2Yixiang Qiu, Xiaoyong Tong, Hui Chen et al.|European Journal of Pharmacology|2025Cited by 1